DuPont's Nutritional Unit is up for bid in a potential $25B deal - Delaware


Sep. 17, 2019 6:19 pm

DuPont’s Nutritional Unit is up for bid in a potential $25B deal

DuPont's nutrition and bioscience division may soon be part of a multi-billion-dollar deal.
Biotech in Delaware.

Biotech in Delaware.

(Photo by Pexels user Martin Lopez, used under a Creative Commons license)

DuPont de Nemours┬áis courting potential bidders, including the Dutch company DSM, Ireland’s Kerry Group and the Swiss company Givaudan, for its Nutritional Unit, which currently has labs at the Experimental Station in Wilmington, Bloomberg reports. The value of the nutrition and bioscience division is believed to be around $25 billion.

According to Bloomberg, DuPont (aka the “new” DuPont, post-Dow merger and Dow/Dupont Inc. breakup) sent confidentiality agreements to prospective buyers; it appears that any reviewing of new deals will be complete by the end of the year.

Kerry and DSM are food and nutrition research companies that aim for solutions to sustainability issues such as food waste, product packaging and food safety. Givaudan is an innovation-focused flavor and fragrance company.

Currently DuPont’s nutrition and bioscience unit has about 50 open jobs. There is no indication whether Delaware jobs will be significantly impacted if a deal takes place.

Companies: DuPont

Already a contributor? Sign in here
Connect with companies from the community
New call-to-action


Sign-up for daily news updates from Delaware

Do NOT follow this link or you will be banned from the site!